CARE Ratings cancels scheduled analyst and investor meet on Sep 3
- CARE Ratings cancelled its analyst and investor meet for September 3, 2026
- The company cited exigencies as the reason for the cancellation
- The meeting was originally scheduled for 8:00 pm IST
- Disclosure made under SEBI LODR Regulation 30 requirements

*this image is generated using AI for illustrative purposes only.
CARE Ratings has cancelled its scheduled analyst and institutional investor meeting that was planned for September 3, 2026. The company cited exigencies as the reason for the cancellation of the event, which was originally set to begin at 8:00 pm.
The rating agency had previously notified stakeholders about the meeting in a letter dated August 20, 2026. The cancellation was communicated via a formal intimation submitted to the stock exchanges.
Regulatory Disclosure
The information regarding the cancellation was submitted pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates timely disclosure of material events to listed entities.
The intimation was signed by Manoj Kumar CV, Company Secretary and Compliance Officer of CARE Ratings Limited. The document was digitally signed and timestamped on September 3, 2026, at 4:10 pm.
Meeting Details
The cancelled session was intended for analysts and institutional investors. It was scheduled to take place on Thursday, September 3, 2026. The company did not provide a new date for the rescheduled meeting in this disclosure.
Historical Stock Returns for CARE Ratings
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.51% | +2.85% | -0.06% | +6.55% | +10.21% | +150.90% |
Will CARE Ratings announce a new date for the investor meeting, and if so, what is the expected timeline for rescheduling?
Could the cited 'exigencies' indicate underlying operational or financial challenges that might impact CARE Ratings' credit outlook or business stability?
How might this sudden cancellation affect institutional investor confidence and short-term trading volume in CARE Ratings' stock?


































